The differences in bladder cancer outcomes between the sexes has again been highlighted.
Uncommon among cancers, bladder cancer outcomes are notably worse for women than for …

The overall survival (OS) improvement after the advent of several novel systemic therapies,
designed for treatment of metastatic urothelial carcinoma of the urinary bladder (mUCUB), is …

Simple Summary Primary urinary tract malignant melanoma represents a rare malignancy.
To date, analyses exclusively addressing contemporary diagnosed patients are unavailable …

Background We tested for other-cause mortality (OCM) differences according to
race/ethnicity in metastatic renal cell carcinoma (mRCC). Such differences may affect …

Background: Female sex in patients treated by radical cystectomy (RC) is associated with
more advanced stage and worse survival. However, studies supporting these findings …

Background The efficacy and safety of enfortumab vedotin combined with pembrolizumab
(EV-PEMB) was investigated as a first-line treatment for advanced urothelial carcinoma (UC) …

Purpose To evaluate the association between radical cystectomy (RC) and cancer-specific
mortality (CSM) in patients diagnosed with adenocarcinoma of the bladder (ACB). Moreover …

METHODS Using the Surveillance, Epidemiology and End Results (SEER) database (2010–
2018), patient (age, sex, race/ethnicity), tumor (T-stage, N-stage, number of metastatic sites) …

Background The numbers needed to image to identify pelvic lymph node and/or distant
metastases in newly diagnosed prostate cancer (PCa) patients according to risk level are …

Introduction Trimodal therapy (TMT) is guideline-recommended for the management of
organ confined urothelial carcinoma of urinary bladder (UCUB). However, temporal trends in …